Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center Where you're treated first, matters. To make an appointment, call (844)-422-9799
(4226)

Connect with us:
www.mskcc.org
https://twitter.com/MSKCancerCenter
www.instagram.com/memorialsloankettering
youtube.com/user/mskcc

Our main campus and inpatient hospital are located on the Upper East Side of Manhattan. We also have outpatient facilities in Commack, Uniondale, and Hauppauge on Long Island, New York; West Harrison in Westchester County, New York; and Basking Ridge, Montvale, and Middletown in New Jersey; as well as several locations in New York City.

Michael has turned his experience with prostate cancer into a commitment to helping others.Because of his family history...
08/12/2026

Michael has turned his experience with prostate cancer into a commitment to helping others.

Because of his family history, Michael began regular PSA (prostate-specific antigen) screenings at age 40. His father died of metastatic prostate cancer in his 50s, and his older brother had been diagnosed with the disease. When Michael turned 52 in 2014, he was also diagnosed with prostate cancer.

Fortunately, his cancer was caught while it was still confined to the prostate. Michael came to MSK, where he underwent a robot-assisted radical prostatectomy and bilateral pelvic lymphadenectomy. He also received care through MSK’s survivorship and erectile rehabilitation programs as he recovered from treatment.

Today, Michael has no evidence of prostate cancer, but his relationship with MSK didn’t end with treatment.

Through his work with MSK’s Patient and Family Advisory Council for Quality (PFACQ), Michael learned about MSK’s programs for people with hereditary cancer syndromes. Given his family history, he decided to pursue genetic counseling. In May 2020, Michael met with MSK geneticist Dr. Alicia Latham and genetic counselor Sarah Kane through telemedicine to discuss his family history and whether genetic testing was right for him.

Testing revealed that Michael carries a BRCA2 mutation. Since then, he has undergone additional cancer screening and surveillance, including regular mammograms, and is currently participating in a clinical trial that studies pancreatic cancer screening in people at high risk.

Outside of his advocacy work, Michael enjoys gardening and traveling with his wife, as well as astrophotography, capturing images of nebulae, galaxies, and star clusters. He has also been a bagpiper with St. Ann’s Pipes and Drums of Hampton since 2005, competing in solo and band competitions.

Leave a ⭐ in the comments for Michael!

An effective new treatment for metastatic prostate cancer is now available to a much larger group of people with the dis...
08/11/2026

An effective new treatment for metastatic prostate cancer is now available to a much larger group of people with the disease.

The FDA has expanded its approval of Pluvicto® (¹⁷⁷Lu-PSMA-617) to be given in combination with hormonal therapy as an initial treatment for patients with metastatic prostate cancer, if a PET scan shows the cancer is positive for the PSMA protein.

Pluvicto is a radioactive molecule that selectively seeks out and attaches to PSMA on the cancer cell surface. It delivers radiation that damages DNA and destroys the cancer cell.

“This type of precision medicine has been a game changer for people whose prostate cancer has spread outside of the prostate,” says Dr. Michael Morris, a genitourinary medical oncologist at MSK.

The latest approval is based on results from a phase 3 clinical trial called PSMAddition. Dr. Morris was a key leader of the study in the U.S.

Learn more about what this expanded approval means for people with metastatic prostate cancer: https://bit.ly/3S8pgbx

At 31, Michael was building a life, working full time, and pursuing his dreams when abdominal pain led to a diagnosis he...
08/10/2026

At 31, Michael was building a life, working full time, and pursuing his dreams when abdominal pain led to a diagnosis he never expected: stage 4 colon cancer that had spread to his liver.

“I had blood in my stool for years, and I just kept telling myself it was hemorrhoids,” Michael says. It wasn’t until abdominal pain sent him to the doctor that he learned the truth. After receiving a grim prognosis near his hometown of Buffalo, Michael and his wife, Sara, sought a second opinion at MSK.

“They really listened to my concerns and treated me like a person, not just a case,” Michael says of his care team, which included gastrointestinal medical oncologist Dr. Louise Connell, colorectal surgeon Dr. Philip Paty, and liver surgeon Dr. T. Peter Kingham.

Michael had multiple tumors in his liver that required a specialized approach. His treatment included 23 total rounds of chemotherapy.

Michael’s care team used hepatic artery pump chemotherapy to shrink the tumors in his liver. He then underwent two additional surgeries and ablations to clear the cancer. Because some of the tumors were located near bile ducts and blood vessels that needed to be preserved, the team used a newer form of ablation that treats tumors with electricity instead of heat. “We've spent years developing tools to treat patients like Michael,” Dr. Kingham says.

Receiving this care meant traveling 250 miles from Buffalo to New York City. With support from Wings of Hope, a nonprofit that provides free flights to patients traveling for specialized care, Michael made the trip more than 50 times over the course of a year.

On May 26, 2021, Michael was declared cancer-free. This past May, he celebrated five years with no evidence of disease.

Today, Michael remains involved with Man Up to Cancer, a nonprofit that helps men avoid isolation during a cancer diagnosis. His advice to others: “Learn about your disease, advocate for yourself, and don’t be afraid to accept help. There are people out there who are willing to help and carry some of that weight with you if you let them.”

Leave a 👏 in the comments for Michael!

👀
08/10/2026

👀

A new blood test called SimpleScreen CRC has been approved by the FDA for adults 45 and older who are at average risk of...
08/04/2026

A new blood test called SimpleScreen CRC has been approved by the FDA for adults 45 and older who are at average risk of colorectal cancer. But MSK experts do not recommend it for colorectal cancer screening because it can miss early-stage cancers and precancerous polyps.

Learn why colonoscopy remains the gold standard and explore your screening options: https://bit.ly/4pXfkOn

👏 Top news! MSK is ranked the #2 cancer center in the nation, the #1 cancer center in New York, and #1 for urology c...
08/04/2026

👏 Top news! MSK is ranked the #2 cancer center in the nation, the #1 cancer center in New York, and #1 for urology care for the 4th year in a row by U.S. News & World Report in its annual Best Hospitals listing.

Read more: https://bit.ly/4pZxjEa

The annual MSK Kids Talent Show brought patients and staff to the stage for nearly 20 acts! 🌟The show featured dance per...
07/31/2026

The annual MSK Kids Talent Show brought patients and staff to the stage for nearly 20 acts! 🌟

The show featured dance performances, joke telling, drawing and painting, puppet shows, and even an original song about MSK. Performers and audience members enjoyed popcorn and ice cream while cheering on every act. Swipe through for some highlights from the show!

Staff Spotlight | “No one wants to be a patient, but if you have to be, there’s truly no place I’d rather it be,” says W...
07/30/2026

Staff Spotlight | “No one wants to be a patient, but if you have to be, there’s truly no place I’d rather it be,” says William Wilson, a senior medical coordinator at MSK Monmouth in New Jersey.

Long before William wore an MSK badge, he walked through MSK’s doors, holding his grandfather’s hand and sitting beside him during treatment. Years later, William’s cousin was diagnosed with a rare form of childhood sarcoma at the age of 16.

William saw firsthand the impact of extraordinary care. Today, those experiences shape how he cares for every patient who walks through the doors of MSK Monmouth, even five years into his career.

From helping lead the rollout of the Epic platform on day one to supporting his peers through all major transitions, William consistently shows up with his best foot forward. His teamwork and willingness to step in wherever he is needed have not gone unnoticed.

William shares: "Knowing the people you're showing up for, seeing them day after day — that's what makes this feel like more than a job. It motivates me every single day.”

Leave a 👏 in the comments for William!

Prostate cancer treatment is now becoming more personalized than ever before. “At MSK, we’ve made many advances in pros...
07/29/2026

Prostate cancer treatment is now becoming more personalized than ever before.

“At MSK, we’ve made many advances in prostate cancer treatment — but just as important, we developed more personalized evaluations to better understand each person’s disease,” says MSK urologic surgeon Dr. Massimiliano Spaliviero.

These evaluations help doctors identify a patient's true level of risk to recommend the most appropriate care. Weather patients undergo surgery, radiation therapy, active surveillance, targeted therapy, or clinical trials.

Swipe to learn how the advances in prostate cancer care are helping reduce unnecessary treatment.

Learn more here: https://bit.ly/44W6FSN

07/28/2026

One of the earliest signs of HPV-related throat cancer may not be in your throat at all.

In our latest , MSK head and neck surgeon Dr. Rebecca Gao explains what to look for, when to take action, and the symptoms you should never ignore.

Share this video with a loved one.

Address

New York, NY

Telephone

+13477989213

Website

Alerts

Be the first to know and let us send you an email when Memorial Sloan Kettering Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Memorial Sloan Kettering Cancer Center:

Shortcuts

Featured

Share

Category